Biotech · Private company
TR Therapeutics
Track this companyFree. Adds TR Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- GLYC-101 Gel (0.1%)Phase 2 · WoundsClinicalTrials.gov · fetched Nov 12, 2026
- GLYC-101 gel (1.0 %)Phase 2 · WoundsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Tissue Repair Gel in Venous Leg Ulcers in AU/USPHASE3 · RECRUITING · started Apr 1, 2025ClinicalTrials.gov NCT06707103 · fetched Nov 12, 2026
- Tissue Repair Gel in Venous Leg Ulcers (US)PHASE3 · RECRUITING · started Jan 28, 2025ClinicalTrials.gov NCT06707090 · fetched Nov 12, 2026
- Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser AblationPHASE2 · COMPLETED · started Oct 1, 2008ClinicalTrials.gov NCT00792688 · fetched Nov 12, 2026
- Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser AblationPHASE1_PHASE2 · COMPLETED · started Mar 1, 2008ClinicalTrials.gov NCT00656474 · fetched Nov 12, 2026